Xxera/openscience/retractions

Record #18004

Efficacy and safety of topical oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: findings from the 2 phase 3, 29-day, randomized, controlled REVEAL trials

Linda Stein-Gold, Leon H Kircik, Zoe Diane Draelos, Philip Werschler, Janet DuBois, Edward Lain, Leslie Baumann, David J Goldberg, Joely Kaufman, Emil A Tanghetti, Nancy Alvandi, Emily Weng, David R Berk, Gurpreet Ahluwalia

Journal

Journal of the American Academy of Dermatology

Publisher

Original paper date

Jan 3, 2018

Original DOI

10.1016/j.jaad.2018.01.028

Country

🇺🇸 United States

Institution

Henry Ford Health System, West Bloomfield · Icahn School of Medicine at Mount Sinai, New York · Dermatology Consulting Services, High Point · Premier Clinical Research, Spokane · DermResearch, Inc, Austin · Austin Institute for Clinical Research · Baumann Cosmetic and Research Institute, Inc, Miami · Skin Laser and Surgery Specialists of NY and NJ, New York · Skin Associates and Skin Research Institute, Coral Gables · Center for Dermatology and Laser Surgery, Sacramento · Allergan plc, Irvine

Open access

No

Article type

Broad categories

(HSC) Medicine - Dermatology (HSC) Medicine - Pharmacology (HSC) Medicine - Rehabilitation/Therapy

Citation lifecycle

How this paper is being cited

Pre-retraction

0

Same day

0

Post-retraction

7

% post-retraction

100.0%

~0.0 citations/yr before retraction · ~0.8 citations/yr after

— citing papers

Who is still citing this work

Loading…